Back
EyePoint Pharmaceuticals Vs. Marblegate Acquisition Industry Stock Comparison
Sell
10
EYPT
EyePoint Pharmaceuticals
Last Price:
$4.61
Seasonality Move:
10.13%
Buy
69
GATE
Marblegate Acquisition
Last Price:
$36.60
Seasonality Move:
2.29%
Sell
10
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $4.60. The Score for EYPT is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
69
Marblegate Acquisition (GATE)
is a Buy
Is Marblegate Acquisition a Buy, Sell or Hold?
-
The current Marblegate Acquisition [GATE] share price is $36.05. The Score for GATE is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
GATE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $4.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
GATE Stock Price Chart
What is Marblegate Acquisition's stock price today?
-
The Marblegate Acquisition share price today is $36.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GATE is experiencing slight buying pressure.
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 28.2 | Sell |
Chaikin Money Flow: | -1093730 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.47 - 6.89) | Sell |
Bollinger Bands (100): | (6.1 - 8.9) | Sell |
GATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.68 | Buy |
Relative Strength Index (14 RSI): | 62.85 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.56 - 30.5) | Buy |
Bollinger Bands (100): | (6.05 - 19.69) | Buy |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.4 | Sell |
20-day SMA: | 6.11 | Sell |
50-day SMA: | 6.51 | Sell |
200-day SMA: | 8.33 | Sell |
8-day EMA: | 5.32 | Sell |
20-day EMA: | 5.84 | Sell |
50-day EMA: | 6.49 | Sell |
200-day EMA: | 8.81 | Sell |
GATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.76 | Buy |
20-day SMA: | 20.43 | Buy |
50-day SMA: | 14.71 | Buy |
200-day SMA: | 11.91 | Buy |
8-day EMA: | 31.73 | Buy |
20-day EMA: | 24.05 | Buy |
50-day EMA: | 17.44 | Buy |
200-day EMA: | 12.72 | Buy |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Marblegate Acquisition Earnings Growth & GATE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
EyePoint Pharmaceuticals Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Marblegate Acquisition Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |